| abstract |
Novel benethamine salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid characterised by their X-ray powder diffraction pattern and solid-state NMR spectra are described, as well as methods for their preparation and pharmaceutical compositions of the same , which are useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, benign prostatic hyperplasia, and Alzheimer's disease. |